Caxton Associates (New York)’s Chemours CC Stock Holding History

Caxton Associates (New York)’s Portfolio CC Stock Details CC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-26,854	Closed	-$401K	–	405
2019 Q3	$401K	Sell	26,854 -5,159	-16%	-$83.9K	0.08%	181
2019 Q2	$768K	Buy	+32,013	New	+$943K	0.09%	112
2019 Q1	–	Sell	-86,759	Closed	-$2.45M	–	388
2018 Q4	$2.45M	Buy	+86,759	New	+$2.74M	0.39%	35
2018 Q2	–	Sell	-115,000	Closed	-$5.6M	–	387
2018 Q1	$5.6M	Buy	+115,000	New	+$5.75M	0.29%	71
2017 Q4	–	Sell	-100,000	Closed	-$5.06M	–	354
2017 Q3	$5.06M	Hold	100,000	–	–	0.18%	123
2017 Q2	$3.79M	Sell	100,000 -65,000	-39%	-$2.56M	0.15%	158
2017 Q1	$6.35M	Sell	165,000 -190,000	-54%	-$5.72M	0.02%	87
2016 Q4	$7.84M	Buy	+355,000	New	+$7.29M	0.35%	58

Other funds holding CC

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return

Greenlight Capital New York $2.05B AUM 78.75% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Caxton Associates (New York)'s CC Position: Q4 2019 in Review

Caxton Associates (New York) sold out of Chemours (CC) in Q4 2019, closing a stake of 26,854 shares — an estimated $401K sold.

Caxton Associates (New York) first reported a position in CC in Q4 2016 and held it in 8 quarters. The position peaked at $7.84M in Q4 2016. 439 funds tracked by Wall St. Rank hold CC as of Q4 2019.

Caxton Associates (New York) reported no remaining Chemours position as of Q4 2019 after selling out during the quarter.
Caxton Associates (New York) sold 26,854 Chemours shares in Q4 2019, an estimated $401K.
Caxton Associates (New York) first reported a position in Chemours in Q4 2016 and held it in 8 quarters.
Caxton Associates (New York)'s Chemours position peaked at $7.84M in Q4 2016.
439 funds tracked by Wall St. Rank held Chemours as of Q4 2019.

Based on Caxton Associates (New York)'s 13F filing for Q4 2019, filed 14 Feb 2020.